'Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets
This paper demonstrates how, by introducing a generic version of its previously patented product, a branded firm can influence the equilibrium in the generic segment of the market for the product. This in turn can increase the firm's profits from selling the branded version. We then use structural estimates from previous literature to calculate the magnitude of the effects in the generic and branded segments. Copyright © 2007 John Wiley & Sons, Ltd.
Year of publication: |
2007
|
---|---|
Authors: | Reiffen, David ; Ward, Michael R. |
Published in: |
Managerial and Decision Economics. - John Wiley & Sons, Ltd., ISSN 0143-6570. - Vol. 28.2007, 4-5, p. 251-265
|
Publisher: |
John Wiley & Sons, Ltd. |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
“BRANDED GENERICS” AS A STRATEGY TO LIMIT CANNIBALIZATION OF PHARMACEUTICAL MARKETS
Ward, Michael R., (2005)
-
Recent Empirical Evidence on Discrimination by Regulated Firms
Reiffen, David, (2002)
-
Generic Drug Industry Dynamics
Reiffen, David, (2005)
- More ...